Allstate (NYSE:ALL) reports sales below analyst estimates in Q3 2026 earnings

Allstate (NYSE:ALL) reported Q3 2026 revenue of $17.35B, missing estimates by 1%. Adjusted EPS of $9.76 beat estimates by 40.2%. Net premiums earned grew 3.2% YoY to $15.86B, beating estimates. Book value per share grew 23.5% YoY to $120.23, missing estimates. The company highlighted growth in auto and homeowners insurance policies and expansion of its Protection Services.

Original reporting
Published Nov 4, 2026, 10:47 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 11:06 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Allstate (NYSE:ALL) reports sales below analyst estimates in Q3 2026 earnings — source image
Decision brief

The 30-second read

$ALLNeutralMed
01

Why it matters

The earnings release provides fresh data for valuation models and may trigger short‑term trading activity.

02

Market read

Allstate's earnings are the primary driver of relevance; sector peers may be indirectly affected.

03

What to watch

Allstate's expanding AI-driven service platform (ALLIE) and international protection plan growth could drive future earnings.

Relevance 8/10Novelty 8/10Timing: after-hours release

Background

Allstate reported Q3 2026 results with mixed outcomes: revenue below estimates, EPS well above expectations, and book value per share missing forecasts.

Company-level read

Ticker impact

$ALLNeutralHigh confidence
Context

Q3 2026 earnings released showing revenue miss versus estimates but EPS beat.

Expected impact

likely modest downside as investors weigh revenue miss against EPS beat

Evidence & confidence

Revenue fell short of consensus, a key driver for insurers, but adjusted EPS beat by 40% may offset some weakness.

Market effects

Insurance sector may see broader scrutiny of premium growth versus revenue expectations.

U.S. market may experience slight pullback in financials as earnings miss is digested.

Limited to insurers; no major cross‑asset impact.

Counterpoint

Investors could view the strong EPS beat as a sign of pricing power and hold the stock despite revenue miss.

Key entities

  • Allstate Corp.

    U.S. insurer reporting Q3 2026 earnings.

Related articles

$ALLMed

Keefe Bruyette raises Allstate stock price target on faster growth

Keefe Bruyette & Woods raised Allstate's (NYSE:ALL) price target to $241 from $232, citing faster growth expectations. They increased 2026-2028 EPS estimates but maintained an Underperform rating. Allstate's Q3 2026 earnings beat expectations, reporting $9.76 EPS and $17.3B revenue. Piper Sandler adjusted its target to $294 from $300, keeping an Overweight rating.

$TRVMed

3 Insurance Dividend Stocks Built to Keep Paying Through Tough Times

Travelers (TRV), Allstate (ALL), and Chubb (CB) are large property and casualty insurers with strong dividend histories. Travelers has raised dividends annually since 2004, yielding 1.17%. Allstate offers the highest yield at 1.59%, while Chubb has the largest market value and diverse earnings. All three maintain low payout ratios and benefit from rising investment income.

$ALLMed

What Allstate (ALL) Said on Its Q3 Earnings Call

Allstate reported Q3 earnings, noting inflation impacts on auto claims and rate adjustments in 39 locations. CEO Tom Wilson discussed reserve developments and an AI assistant planned for 2027. Net investment income rose 24%, but the portfolio saw a -2.1% return. Allstate returned $1.5B to shareholders in Q3 and repurchased 5.7% of its shares over 12 months. The company will continue quarterly reporting while focusing on long-term trends.

$ALLMed

Allstate Corp (ALL) (Q3 2026) Earnings Call Highlights: Strong Policy Growth

Allstate Corp (ALL) reported Q3 2026 earnings with a 6.5-point increase in the Property-Liability combined ratio due to higher catastrophe losses. Auto insurance premiums decreased 2.7% year-over-year. The company faces regulatory scrutiny and rising technology costs. CEO Thomas Wilson addressed investor concerns about auto loss ratios, AI investments, and regulatory challenges. Prior-year reserve releases boosted profitability but are not expected to recur at the same level.